{ "items": [ "\n\n
\n \n Journal article\n \n
\n \n\n \n \n \nBai\u00e3o R. et al, (2022), Psychol Med, 1 - 11
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nTamm S. et al, (2022), American Journal of Psychiatry
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nBas-Hoogendam JM. et al, (2022), Human Brain Mapping, 43, 83 - 112
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nde Cates AN. et al, (2022), Front Psychiatry, 13
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nMacoveanu J. et al, (2021), Journal of Affective Disorders, 295, 647 - 656
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nHarmer CJ. and Browning M., (2021), Eur Neuropsychopharmacol, 56, 1 - 3
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nKaltenboeck A. et al, (2021), Psychopharmacology (Berl)
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nJonassen R. et al, (2021), BMC Public Health, 21
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nFinnegan SL. et al, (2021), Eur Respir J, 58
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nDE GIORGI R. et al, (2021), Journal of Psychopharmacology
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nDawson GR. et al, (2021), J Psychopharmacol
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nde Cates AN. et al, (2021), Transl Psychiatry, 11
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nMartens MAG. et al, (2021), Psychopharmacology (Berl)
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nMurphy SE. et al, (2021), Lancet Psychiatry, 8, 824 - 835
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nRuzickova T. et al, (2021), Psychol Med, 1 - 18
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nMartens MAG. et al, (2021), Pharmaceuticals (Basel), 14
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nSyed Sheriff RJ. et al, (2021), Trials, 22
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nBrowning M. et al, (2021), Neuropsychopharmacology, 46, 1307 - 1314
\n \n \n \n\n
\n \n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nPULCU E. et al, (2021), Molecular Psychiatry
\n \n \n \n\n \n
\n \n \n\n \n Journal article\n \n
\n \n\n \n \n \nZarp Petersen J. et al, (2021), Bipolar Disord
\n \n \n \n\n
\n \n \n \n